Guardant Health, Inc. (GH)

Guardant Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-479.45	-654.59	-405.67	-253.78	-75.65
Depreciation & Amortization	42.88	35.96	22.27	21.63	15.82
Share-Based Compensation	90.76	94.69	151.45	144.11	16.95
Other Operating Activities	20.83	214.48	22.93	-15.89	-4.26
Operating Cash Flow	-324.98	-309.46	-209.02	-103.93	-47.13
Capital Expenditures	-20.49	-77.46	-75.04	-54.06	-21.22
Acquisitions	0	0	0	0	-7.33
Change in Investments	859.21	227.28	11.88	-563.03	-288.96
Other Investing Activities	1.53	-	-	-	-0.07
Investing Cash Flow	840.25	149.82	-63.16	-617.09	-317.57
Share Issuance / Repurchase	503.68	11.94	17.87	371.22	367.74
Debt Issued / Paid	0	0	0	1,133	-0.13
Other Financing Activities	-26.3	-201.03	-84.69	-93.49	-0.31
Financing Cash Flow	477.38	-189.09	-66.82	1,410	367.3
Exchange Rate Effect	-0.91	-1.6	-1.69	0.46	0.08
Net Cash Flow	991.74	-350.34	-340.69	689.75	2.68
Free Cash Flow	-345.46	-386.92	-284.05	-157.99	-68.35
Free Cash Flow Margin	-61.26%	-86.07%	-76.02%	-55.10%	-31.88%
Free Cash Flow Per Share	-3.08	-3.79	-2.80	-1.62	-0.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).